Andrew Livermore

Using the epigenetic field defect to detect prostate cancer in biopsy negative patients.

R. Dhir, J. Nelson, D. Lin, 2013, The Journal of urology.

Impact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.

Wei Huang, D. Jarrard, T. Laurila, 2013, Urologic oncology.